A Real-World Study of Precision Treatment for Advanced Cholangiocarcinoma Based on Molecular Subtyping

NCT07164703 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cholangiocarcinoma (Part 1)

Interventions

DRUG: Targeted drugs or immunotherapies for cholangiocarcinoma based on targetable gene mutations.

Sponsor

Mao-Lin Yan